Company / Interest Expense
Elanco Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$277.0M
FY2023
5-year range
$236.0M / $277.0M
FY2019-FY2023
Trend
+14.9%
vs FY2022
Sector context
#8 of 44
Health Care
What the data says
Elanco's interest expense of $277M is higher than 82% of companies in the Health Care sector (FY2023). Interest Expense has increased for 6 consecutive years, from $0 in FY2017 to $277M in FY2023.
Based on SEC 10-K filings.
$277M in FY2023 with a 5-year CAGR of +56.4%. Top quartile in the Health Care sector.
Increased from $236M to $277M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +22.7%
- 5-Year CAGR
- +56.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 44This company $277.0M Sector average $291.0M
▼
-4.8% below sector average
Key checks
Key Insights
- Elanco's interest expense has grown for 5 consecutive years.
- 5-year CAGR of +56.4%, indicating consistent growth.
- In FY2023, interest expense increased 14.9% year-over-year.
- Ranks #8 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $277.0M | +14.9% |
| FY2022 | $241.0M | +2.1% |
| FY2021 | $236.0M | +57.3% |
| FY2020 | $150.0M | +89.9% |
| FY2019 | $79.0M | +166.9% |
| FY2018 | $29.6M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026